Corporate diversity practices, long celebrated for driving revenue growth and stabilizing stock prices, are now being targeted as liabilities by conservative shareholder activists, consumer boycotts, and litigation. This shift from rainbow capitalism to today’s anti-woke agenda reveals how diversity's value in the marketplace has always been politically and legally constructed.

The Manhattan Institute's obsessive focus on trans medicine is a part of its broader effort to erode public trust in medical professionals and federal health authorities.

We live in a condition in which capital drives significant social reforms while also undermining their impact and longevity by leaving destabilizing matters of economic inequality unaddressed. From this perspective, current LGBTQ+ victories are built on a shoddy foundation.